Progression of coronary calcification in pediatric chronic kidney disease stage 5

Pediatric Nephrology

Volumn 24, Issue 3, 2009, Pages 555-563

  Civilibal, Mahmut ^a,b   Caliskan, Salim ^a   Kurugoglu, Sebuh ^a   Candan, Cengiz ^a   Canpolat, Nur ^a   Sever, Lale ^a   Kasapcopur, Ozgur ^a   Arisoy, Nil ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Child; Chronic kidney disease; Coronary artery calcification; Dialysis; Transplantation; Young adult

Indexed keywords

AZATHIOPRINE; CALCITRIOL; CALCIUM; CORTICOSTEROID; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHATE BINDING AGENT; PHOSPHORUS; SEVELAMER; TACROLIMUS;

ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; ARTERY CALCIFICATION; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DISEASE COURSE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM;

ADOLESCENT; ADULT; CALCINOSIS; CHILD; CHOLESTEROL, LDL; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY DISEASES; MALE; PROSPECTIVE STUDIES; SERUM ALBUMIN; YOUNG ADULT;

EID: 59849110786     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-1038-0     Document Type: Article

References (54)

1. Foley RN, Parfrey PS, Sarnak MJ (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9 [Suppl 12]:S16-S23
2. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 432:1478-1483
3. Eifinger F, Wahn F, Querfeld U, Pollok M, Gevargez A, Kriener P, Grönemeyer D (2000) Coronary artery calcifications in children and young adults treated with renal replacement therapy. Nephrol Dial Transplant 15:1892-1894
4. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100-105
5. Briese S, Wiesner S, Will JC, Lembcke A, Opgen-Rhein B, Nissel R, Wernecke KD, Andreae J, Haffner D, Querfeld U (2006) Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease - impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21:1906-1914
6. Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D, Ellins EA, Storry C, Ridout D, Deanfield J, Rees L (2007) Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 18:2996-3003
7. Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Kuruoglu S, Arisoy N (2006) Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 21:1426-1433
8. Moe SM, O'Neill KD, Reslerova M, Fineberg N, Persohn S, Meyer CA (2004) Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant 19:2387-2393
9. Stompor T, Pasowicz M, Sulowicz W, Dembinska-Kiec A, Tracz W (2004) Trends in coronary artery calcification in peritoneal dialysis and transplant patients. Nephrol Dial Transplant 19:3205-3206
10. Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K (2001) Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 38:64-69
11. Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252
12. Asmus HG, Braun J, Krause R, Brunkhorst R, Holzer H, Schulz W, Neumayer HH, Raggi P, Bommer J (2005) Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant 20:1653-1661
13. Jung HH, Kim SW, Han H (2006) Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant 21:1915-1920
14. Yuen D, Pierratos A, Richardson RM, Chan CT (2006) The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplant 21:1407-1412
15. De Lima JJ, Vieira ML, Viviani LF, Medeiros CJ, Ianhez LE, Kopel L, de Andrade JL, Krieger EM, Lage SG (2002) Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients. Nephrol Dial Transplant 17:645-651
16. Litwin M, Wühl E, Jourdan C, Niemirska A, Schenk JP, Jobs K, Grenda R, Wawer ZT, Rajszys P, Mehls O, Schaefer F (2008) Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant 23:2552-2557
17. Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O (2006) Body mass index references for Turkish children. Acta Paediatr 95:194-198
18. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827-832
19. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731-1740
20. Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma T, Takishita S (2004) Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 8:54-58
21. Mitsnefes MM (2008) Cardiovascular complications of pediatric chronic kidney disease. Pediatr Nephrol 23:27-39
22. Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, Erzengin F, Tepe S (2005) Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant 20:760-767
23. Haydar AA, Hujairi NMA, Covic AA, Pereira D, Rubens M, Goldsmith DJA (2004) Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: A study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 19:2307-2312
24. Moe SM, O'Neill KD, Fineberg N, Persohn S, Ahmed S, Garret P, Meyer CA (2003) Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transplant 18:1152-1158
25. Qunibi WY (2005) Reducing the burden of cardiovascular calcification in patients with chronic kidney disease. J Am Soc Nephrol 16 [Suppl 2]:S95-S102
26. Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N, Vascular Calcification Work Group (2004) Vascular calcification in chronic kidney disease. Am J Kidney Dis 43:572-579
27. Salusky IB, Goodman WG (2000) Managing phosphate retention: Is a change necessary? Nephrol Dial Transplant 15:1738-1742
28. Milliner DS, Zinsmeister AR, Lieberman E, Landing B (1990) Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931-936
29. Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ, Singhal A, Merryweather I, Brogan P, Shanahan C, Deanfield J, Rees L (2008) The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 23:3263-3271
30. Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F (2005) Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494-1500
31. Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y (2004) Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19:179-184
32. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA Jr, Thadhani R (2005) Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol 16:1115-1125
33. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG (2006) Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 70:1858-1865
34. Tentori F (2007) Focus on vitamin D therapy in chronic kidney disease. J Nephrol 20:511-514
35. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349:446-456
36. Wolf M, Thadhani R (2007) Vitamin D in patients with renal failure: A summary of observational mortality studies and steps moving forward. J Steroid Biochem Mol Biol 103:487-490
37. London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Metivier F (2007) Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:613-620
38. Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, Hiorns MP, Deanfield JE, Rees L (2008) A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 19:1239-1246
39. McCullough PA (2005) Effect of lipid modification on progression of coronary calcification. J Am Soc Nephrol 16 [Suppl 2]:S115-S119
40. Chertow GM (2003) Slowing the progression of vascular calcification in hemodialysis. J Am Soc Nephrol 14 [Suppl 4]:S310-S314
41. Oschatz E, Benesch T, Kodras K, Hoffmann U, Haas M (2006) Changes of coronary calcification after kidney transplantation. Am J Kidney Dis 48:307-313
42. Schankel K, Robinson J, Bloom RD, Guerra C, Rader D, Joffe M, Rosas SE (2007) Determinants of coronary artery calcification progression in renal transplant recipients. Am J Transplant 7:2158-2164
43. Ligtenberg G, Hene RJ, Blankestijn PJ, Koomans HA (2001) Cardiovascular risk factors in renal transplant patients: Cyclosporin A versus tacrolimus. J Am Soc Nephrol 12:368-373
44. Oflaz H, Turkmen A, Kazancioglu R, Kayacan SM, Bunyak B, Genchallac H, Erol B, Mercanoglu F, Umman S, Sever MS (2003) The effect of calcineurin inhibitors on endothelial function in renal transplant recipients. Clin Transplant 17:212-216
45. Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Vos PF, Blom HJ, Sweep FC, Demacker PN, Hilbrands LB (2003) Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus. J Am Soc Nephrol 14:1880-1888
46. Schmermund A, Baumgart D, Möhlenkamp S, Kriener P, Pump H, Grönemeyer D, Seibel R, Erbel R (2001) Natural history and topographic pattern of progression of coronary calcification in symptomatic patients: An electron-beam CT study. Arterioscler Thromb Vasc Biol 21:421-426 symptomatic patients: An electron-beam CT study
47. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ (1998) Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339:1972-1978
48. Sigrist MK, Taal MW, Bungay P, McIntyre CW (2007) Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2:1241-1248
49. Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK (2004) Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 19:1489-1496
50. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y (2004) Impairment of small intestinal protein assimilation in patients with end-stage renal disease: Extending the malnutrition-inflammation-atherosclerosis concept. Am J Clin Nutr 80:1536-1543
51. Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE (2001) Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 12:1927-1936
52. Stompor T, Pasowicz M, Sullowicz W, Dembinska-Kiec A, Janda K, Wojcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E (2003) An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 41:203-211
53. Tonbul HZ, Demir M, Altintepe L, Güney I, Yeter E, Türk S, Yeksan M, Yildiz A (2006) Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients. Ren Fail 28:287-294
54. Akdag I, Yilmaz Y, Kahvecioglu S, Bolca N, Ercan I, Ersoy A, Gullulu M (2008) Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: A 5-year prospective study. Nephron Clin Pract 108:99-105